Talk:Diagnostic Kits: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
* definition of IVD | * definition of IVD | ||
** see glossary; look for FDA definition | ** [[Diagnostic_Kits/Glossary#In-Vitro_Diagnostic_.28IVD.29 | see glossary; look for FDA definition]] | ||
* Genetic Diagnostic (a kind of molecular diagnostic IVDs) | * Genetic Diagnostic (a kind of molecular diagnostic IVDs) | ||
** need glossary definition | |||
* Industry statistics: number of companies, combined revenue, growth, name major companies, describe pattern of company sizes in the industry, describe the GDx company archetypes. | * Industry statistics: number of companies, combined revenue, growth, name major companies, describe pattern of company sizes in the industry, describe the GDx company archetypes. | ||
Revision as of 14:27, 14 December 2009
Field Definition
working definition
- definition of IVD
- Genetic Diagnostic (a kind of molecular diagnostic IVDs)
- need glossary definition
- Industry statistics: number of companies, combined revenue, growth, name major companies, describe pattern of company sizes in the industry, describe the GDx company archetypes.
- link to deeper industry overview, see Biotechnology_-_Genomic_and_Proteomics#Basic_Definition
Focus Market Segments
From initial R&D to the moment when a target product is developed for licensing to Pharmaceutical or Agricultural companies, we will study the following:
- Data production: Genomic or proteomic sequences, disease linkages, biomarker discovery
- Narrative production: Journals focused on biotechnology and related disciplines; publications of data; descriptions of tools or patents, or commentaries on them
- Tool production: processes for producing data or physical products, GDx techniques
Deprioritized Market Segments
- post-commercialization marketing
- regulatory?
Excluded From Field Definition
- non-genetic IVDs
- ?